FI853456L - Expektorant. - Google Patents

Expektorant.

Info

Publication number
FI853456L
FI853456L FI853456A FI853456A FI853456L FI 853456 L FI853456 L FI 853456L FI 853456 A FI853456 A FI 853456A FI 853456 A FI853456 A FI 853456A FI 853456 L FI853456 L FI 853456L
Authority
FI
Finland
Prior art keywords
expectorant
expektorant
acetyineuramin
sputum
acting
Prior art date
Application number
FI853456A
Other languages
English (en)
Other versions
FI83963C (fi
FI83963B (fi
FI853456A0 (fi
Inventor
Sadanori Ogasawara
Takashi Hanafusa
Katsuhide Kariya
Masayoshi Ito
Yoshiyasu Shitori
Original Assignee
Kanto Ishi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanto Ishi Pharma Co Ltd filed Critical Kanto Ishi Pharma Co Ltd
Publication of FI853456A0 publication Critical patent/FI853456A0/fi
Publication of FI853456L publication Critical patent/FI853456L/fi
Application granted granted Critical
Publication of FI83963B publication Critical patent/FI83963B/fi
Publication of FI83963C publication Critical patent/FI83963C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI853456A 1984-09-11 1985-09-10 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara salter av n-acetylneuraminsyra. FI83963C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59189950A JPS6168418A (ja) 1984-09-11 1984-09-11 去痰薬
JP18995084 1984-09-11

Publications (4)

Publication Number Publication Date
FI853456A0 FI853456A0 (fi) 1985-09-10
FI853456L true FI853456L (fi) 1986-03-12
FI83963B FI83963B (fi) 1991-06-14
FI83963C FI83963C (fi) 1991-09-25

Family

ID=16249907

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853456A FI83963C (fi) 1984-09-11 1985-09-10 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara salter av n-acetylneuraminsyra.

Country Status (14)

Country Link
US (1) US4698332A (fi)
EP (2) EP0429430B1 (fi)
JP (1) JPS6168418A (fi)
KR (1) KR880001234B1 (fi)
CN (1) CN85108388B (fi)
AT (2) ATE94396T1 (fi)
AU (1) AU582584B2 (fi)
CA (1) CA1246452A (fi)
DE (2) DE3587587T2 (fi)
DK (1) DK165046C (fi)
ES (1) ES8606323A1 (fi)
FI (1) FI83963C (fi)
HU (2) HU197515B (fi)
ZA (1) ZA856905B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61289037A (ja) * 1985-06-14 1986-12-19 Mect Corp 新規去痰薬
GB8519416D0 (en) * 1985-08-01 1985-09-04 Unilever Plc Oligosaccharides
JPH0530649Y2 (fi) * 1986-08-28 1993-08-05
JP2573594B2 (ja) * 1987-03-06 1997-01-22 メクト株式会社 Ｎーアセチルー３ーフルオローノイラミン酸誘導体およびその製造方法
US5843445A (en) * 1987-06-24 1998-12-01 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
JP2517293B2 (ja) * 1987-06-25 1996-07-24 メクト株式会社 細胞、組織修復剤
US5393742A (en) * 1990-08-30 1995-02-28 Mect Corporation Preparation for treating renal disease
US5514665A (en) * 1993-12-30 1996-05-07 University Of British Columbia Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
AUPM411494A0 (en) * 1994-02-25 1994-03-24 Central Sydney Area Health Service Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum
US5856446A (en) * 1995-07-07 1999-01-05 Autoimmune Inc. Method of treating rheumatoid arthritis with low dose type II collagen
AUPQ275799A0 (en) 1999-09-10 1999-10-07 Luminis Pty Limited Recombinant bacterium expressing an oligosaccharide receptor mimic
JP4005115B1 (ja) 2007-02-08 2007-11-07 日本臓器製薬株式会社 疼痛疾患治療剤
US9241896B2 (en) * 2008-12-19 2016-01-26 Ultragenyx Pharmaceutical Inc. Methods and formulations for treating sialic acid deficiencies
UA110325C2 (en) * 2009-07-03 2015-12-25 Australian Biomedical Company Pty Ltd Medicinal carbohydrates for treating respiratory conditions
EP2593109A4 (en) 2010-07-13 2014-01-08 Ultragenyx Pharmaceutical Inc METHOD AND FORMULATIONS FOR THE TREATMENT OF SIALIC ACID DEFICIENCIES
WO2013063149A1 (en) 2011-10-24 2013-05-02 Ultragenyx Pharmaceutical, Inc. Sialic acid analogs
US11246878B2 (en) * 2013-03-15 2022-02-15 B&H Biotechnologies, Llc Compositions and products for infectious or inflammatory diseases or conditions
WO2014151526A1 (en) 2013-03-15 2014-09-25 Huiru Wang Biological therapeutics for infection-relating disorders or conditions
WO2016017677A1 (ja) * 2014-07-30 2016-02-04 協和発酵バイオ株式会社 Ｎ－アセチルノイラミン酸アルカリ金属塩・無水和物の結晶及びその製造方法
WO2016121810A1 (ja) * 2015-01-28 2016-08-04 協和発酵バイオ株式会社 Ｎ－アセチルノイラミン酸アンモニウム塩・無水和物の結晶及びその製造方法
WO2017048817A1 (en) 2015-09-14 2017-03-23 Ultragenyx Pharmaceutical Inc. Crystal forms of sialic acid or salt or solvate thereof
CN109771316B (zh) * 2018-12-29 2022-02-25 中国科学院合肥物质科学研究院 一种提高n-乙酰神经氨酸水溶液稳定性的方法及其应用
CN110606864B (zh) * 2019-10-08 2023-10-10 中国科学院合肥物质科学研究院 一种n-乙酰神经氨酸钙盐晶体及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1177863B (it) * 1984-07-03 1987-08-26 Fidia Farmaceutici Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
IT1182209B (it) * 1985-02-18 1987-09-30 Fidia Farmaceutici Uso terapeutico del monosialoganglioside gm1 e dei suoi derivati in gravi patologie di infarti cerebrali

Also Published As

Publication number Publication date
ATE111738T1 (de) 1994-10-15
ATE94396T1 (de) 1993-10-15
DE3587928T2 (de) 1995-01-26
EP0429430A3 (en) 1991-10-23
DE3587587T2 (de) 1994-03-31
FI83963C (fi) 1991-09-25
CA1246452A (en) 1988-12-13
DE3587587D1 (de) 1993-10-21
CN85108388B (zh) 1988-08-24
EP0177783A2 (en) 1986-04-16
DE3587928D1 (de) 1994-10-27
JPS6168418A (ja) 1986-04-08
DK413785D0 (da) 1985-09-11
FI83963B (fi) 1991-06-14
KR860002525A (ko) 1986-04-26
FI853456A0 (fi) 1985-09-10
CN85108388A (zh) 1987-06-03
AU4719985A (en) 1986-03-20
ES8606323A1 (es) 1986-04-16
KR880001234B1 (ko) 1988-07-12
DK413785A (da) 1986-03-12
EP0177783B1 (en) 1994-09-21
HU197515B (en) 1989-04-28
HUT40804A (en) 1987-02-27
DK165046B (da) 1992-10-05
ES546840A0 (es) 1986-04-16
EP0177783A3 (en) 1989-02-22
JPS6328411B2 (fi) 1988-06-08
HU198733B (en) 1989-11-28
EP0429430A2 (en) 1991-05-29
EP0429430B1 (en) 1993-09-15
US4698332A (en) 1987-10-06
ZA856905B (en) 1986-06-25
DK165046C (da) 1993-02-22
AU582584B2 (en) 1989-04-06

Similar Documents

Publication Publication Date Title
FI853456L (fi) Expektorant.
DE3671367D1 (de) Arzneistoffadsorbate und deren herstellung.
EP0276543A3 (en) Use of buspirone for the improvement of short term memory
DE3864188D1 (de) Kondom.
IT8820550A0 (it) Benzammidi sostituite farmacologicamente attive.
NO167660C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylmetylazoler og salter derav.
DE3680000D1 (de) Stabilisierte aktive formen von vitamin-d3.
DE3884295D1 (de) Säure-Urease und ihre Herstellung.
DK166343C (da) Forbedret piroxicamholdigt laegemiddel
FR2617502B1 (fr) Preparation enzymatique d'anhydro-1,5 d fructose
FR2603284B1 (fr) Derives d'acide 7-oxabicyclo(2.2.1.)heptane hydroxamique a action therapeutique
FI862566A (fi) Foerfarande foer framstaellning av nya penemderivat.
FI851151L (fi) Anordning foer bestaemning av mikroorganismer.
IT8619594A0 (it) Acid 8-osso-2-ossa-1-azabiciclo 4.2.0 ottano-3-carbossilici.
FR2567754B1 (fr) Application therapeutique d'aminomethylene-2 indanediones-1,3 substituees sur l'azote
FI865244A0 (fi) Foerfarande foer framstaellning av optiskt aktiva 2-klor-12-(3-dimetylamino-2-metylpropyl)-12h-dibenzo-/d,g//1,3,6/ dioxazociner.
NO164539C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 5-nafthyl-2,4-dimethyl-3h-1,2,4-triazol-3-thion.
NO164657C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,8-nafthyridinoner.
BR8702092A (pt) Agenda-calendaria integral,perpetua e universal
IT8721769A0 (it) Tioderivati beta-lattamici farmacologicamente attivi eprocedimento per la loro preparazione.
IT8748216A0 (it) Procedimento per la produzione di xilanasi, e xilanasi cosi' ottenuta
ATE32712T1 (de) Biologisch wirksame amid-derivate.
NO870621D0 (no) Biologisk aktive copolymere.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: MECT CORPORATION